Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: Preliminary results of Radiation Therapy Oncology Group 0424 - Fisher, B J; Hu, C; Macdonald, D R (Int J Radiat Oncol Biol Phys, 2015)
et al.